Shannon Chatham, doctor of osteopathic medicine and family medicine physician at Wisp, says Wegovy is one of the most effective and well-studied weight management options out there
Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Management
Regulatory bodies approved GLP-1 receptor agonists for glycemic control include: Dulaglutide (subcutaneous-SC), exenatide injectable solution subcutaneous, exenatide injectable suspension SC, liraglutide SC, liraglutide/insulin degludec , lixisenatide/insulin glargine, semaglutide (oral, SC), tirzepatide (dual GIP/GLP-1 receptor agonist) and others
This tri-agonist design allows researchers to study how multiple endocrine signaling pathways interact simultaneously, providing insight into integrated metabolic regulation rather than isolated receptor activity
The reason GLP-1 is everywhere right now is because prescription GLP-1 drugs and GLP-1/GIP drugs have strong clinical evidence for weight loss and blood sugar management
(Ohanian is an investor in Ro and serves on its board.) GLP-1 drugs, also known as GLP-1 agonists, work by mimicking a hormone that the body produces after eating
